Stay updated on Risankizumab in Ulcerative Colitis Clinical Trial
Sign up to get notified when there's something new on the Risankizumab in Ulcerative Colitis Clinical Trial page.

Latest updates to the Risankizumab in Ulcerative Colitis Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe Record History now includes an added revision entry for v3.3.2 and removes the v3.2.0 entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check26 days agoChange DetectedThe page no longer displays the government funding and NIH operating status notice. This change does not affect the clinical trial data or submission process.SummaryDifference0.2%

- Check41 days agoChange DetectedVersion history shows minor metadata updates and intermittent IPDSharing tagging; core study information such as design and outcomes remains unchanged.SummaryDifference0.0%

- Check69 days agoChange Detected- Added a prominent operations/status notice and updated to v3.2.0. - Removed reference to v3.1.0.SummaryDifference6%

- Check76 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

- Check91 days agoChange DetectedUpdated revision to v3.0.2; removed 'Back to Top'.SummaryDifference0.4%

Stay in the know with updates to Risankizumab in Ulcerative Colitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab in Ulcerative Colitis Clinical Trial page.